 |
|
Werner Henrich, Chairman,
was born 1943 and is a French citizen. He has an education as a chemist
and European patent attorney. He worked for F. Hoffmann-La
Roche Ltd. ("Roche") in Basel for more than 30 years. Mr. Henrich held
various positions at Roche including Head of Global Intellectual
Property and Pharmaceutical Licensing for more than 12 years. He was
also a member of the Roche Pharmaceutical Division Executive Board. In
this function Mr. Henrich was responsible for intellectual property
activities of all Roche divisions and for major pharmaceutical
transactions including research collaborations, patent settlements,
licensing-in and -out as well as product acquisitions. From February
2001 to October 2001, Mr. Henrich acted as CEO of Basilea. He retired
from Roche in November 2003. Mr. Henrich has a wide experience in the
pharmaceutical industry both with start-ups and large pharmaceutical
companies. Mr. Henrich is also a member of the board of directors of
Actelion Ltd., Allschwil and Addex Pharmaceuticals Ltd., Geneva, Swiss
biopharmaceutical companies listed on the SIX Swiss Exchange. He acts
as a consultant for several biopharmaceutical companies on a part-time
basis. |
